In this episode, we explore the groundbreaking role of T-cell immunology in early disease detection and innovative immunotherapy treatments with Dr. Nigel McCracken, Chief Operating Officer at Virax Biolabs. With over 25 years of experience in oncology and infectious disease research, Dr. McCracken shares his insights on how T-cell diagnostics are reshaping the landscape of immune health.

Virax Biolabs is leading the charge in diagnostic testing and personalized medicine, leveraging state-of-the-art biotechnology to combat chronic inflammation, immune dysfunction, and post-viral conditions. Their pioneering work in adaptive immunity is driving advancements in vaccineresearch and autoimmune disorders, offering new hope for patients worldwide.

Before joining Virax, Dr. McCracken played key roles in companies like BerGenBio ASA and NuCana PLC, spearheading oncology research, companion diagnostics, and next-generation therapeutic strategies.

Tune in now to discover:

• The critical role of T-cells in the fight against chronic illness.
• How immune system dysfunction contributes to conditions like long COVID and post-viral syndrome.
• The evolving future of medical diagnostics, immune health, and public health.
• What makes T-cell therapy a game-changer in immunotherapy and inflammation awareness.

Follow Dr. McCracken’s latest work at Virax Biolabs to stay at the forefront of immune system health innovation!

Episode also available on Apple Podcasts: https://apple.co/38oMlMr